These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 21046289)
1. Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel. Donohue MM; Tirschwell DL Curr Neurol Neurosci Rep; 2011 Feb; 11(1):52-60. PubMed ID: 21046289 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin. George J; Doney A; Palmer CN; Lang CC Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312 [No Abstract] [Full Text] [Related]
3. Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran. Ross S; Paré G Pharmacogenomics; 2013 Oct; 14(13):1565-72. PubMed ID: 24088127 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and cardiovascular disease--implications for personalized medicine. Johnson JA; Cavallari LH Pharmacol Rev; 2013 Jul; 65(3):987-1009. PubMed ID: 23686351 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of Stroke. Ross S; Paré G Stroke; 2018 Oct; 49(10):2541-2548. PubMed ID: 30355125 [No Abstract] [Full Text] [Related]
6. Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice? Shahin MH; Johnson JA Curr Opin Cardiol; 2013 May; 28(3):305-14. PubMed ID: 23478884 [TBL] [Abstract][Full Text] [Related]
7. The role of warfarin and aspirin in secondary prevention of stroke. Elkind MS Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359 [TBL] [Abstract][Full Text] [Related]
14. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes. Furlan AJ Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635 [No Abstract] [Full Text] [Related]
15. Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure. Kozdağ G; Yaymacı M; Ertaş G; Celikyurt U; Sahin T; Kılıç T; Ural D Heart Vessels; 2012 Nov; 27(6):568-75. PubMed ID: 21909806 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of anti-platelet and anti-coagulation therapy. Fisch AS; Perry CG; Stephens SH; Horenstein RB; Shuldiner AR Curr Cardiol Rep; 2013 Jul; 15(7):381. PubMed ID: 23797323 [TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation, is warfarin the only option for stroke prevention? Khan M; Kamal AK J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955 [No Abstract] [Full Text] [Related]
18. Good old warfarin for stroke prevention in atrial fibrillation. Verheugt FW Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740 [No Abstract] [Full Text] [Related]
19. Watching the WATCH trial: the role of sponsors and data monitoring committees. Califf RM J Card Fail; 2004 Apr; 10(2):113-4. PubMed ID: 15101021 [No Abstract] [Full Text] [Related]
20. Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke. Fabiaña N; Ramaswami AP; Ang ES; De Silva DA Ann Acad Med Singap; 2015 Jul; 44(7):266-8. PubMed ID: 26377061 [No Abstract] [Full Text] [Related] [Next] [New Search]